Casey Grover, MD, FACEP
Casey Grover, MD, FACEP
Episode 49 - Buprenorphine vs Fentanyl
Episode 49 - Buprenorphine vs Fentanyl
Episode 49 - Buprenorphine vs Fentanyl
Wednesday 19th April 2023
Join Dr. Casey Grover as he unpacks a study on buprenorphine inductions in fentanyl users, offering new insights into opioid withdrawal risks.
19 minutes
Informative
Empowering
Inspiring
Supportive
Thought-provoking
About this podcast
Author:
Casey Grover, MD, FACEP
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Navigating Intimate Relationships
Nutritional Pathways to Recovery
Links:
Visit site
Episodes:
110 (View all)
Do you want to link to this podcast?
Get the buttons here!Buprenorphine vs Fentanyl: Breaking Down the Risks of Opioid Withdrawal
Episode Overview
- A recent study challenges common expectations regarding precipitated opioid withdrawal during buprenorphine inductions in patients using fentanyl.
- Less than 5% of patients using fentanyl developed precipitated withdrawal when starting buprenorphine, providing valuable insights for healthcare providers.
- The study emphasizes the importance of reducing patient anxiety during buprenorphine inductions, aiming to improve treatment experiences for patients with opioid use disorder.
- The findings highlight the effectiveness of high-dose buprenorphine administration in the emergency department for patients in withdrawal, particularly in fentanyl-exposed populations.
- Dr. Casey Grover advocates for leveraging the study's insights to enhance the care and support provided to individuals with substance use disorders.
Treating substance use disorders saves lives.
Picture this: you're in the emergency room, and a patient with opioid use disorder walks in, worried about the risk of withdrawal from fentanyl. In this episode, Dr. Casey Grover dives into a groundbreaking study from JAMA Network Open that tackles this very issue. The focus? Comparing the rate of precipitated opioid withdrawal during buprenorphine inductions in patients using fentanyl. It's a topic that's been causing a lot of concern among both patients and healthcare providers. Dr.
Grover breaks down the study's findings, which might just turn some common expectations on their head. If you're a healthcare professional dealing with opioid use disorder, this episode is packed with insights you won't want to miss. From real-world applications to the nitty-gritty of the study, Dr. Grover's discussion offers a fresh perspective on managing opioid withdrawal in acute care settings.